{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:10:23Z","timestamp":1756278623872,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1136\/dtb.2022.243568.rep","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T06:32:32Z","timestamp":1673937152000},"page":"92-95","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Republished: Acute interstitial nephritis secondary to vedolizumab"],"prefix":"10.1136","volume":"61","author":[{"given":"Nicholas","family":"Simpson","sequence":"first","affiliation":[{"name":"Queen Elizabeth University Hospital, NHSGGC, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1524-1080","authenticated-orcid":false,"given":"John Paul","family":"Seenan","sequence":"additional","affiliation":[{"name":"Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Patel","sequence":"additional","affiliation":[{"name":"Nephrology, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kipgen","sequence":"additional","affiliation":[{"name":"Pathology, Beatson West of Scotland Cancer Centre, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"2025082623441022000_61.6.92.1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMe1307415","article-title":"Inhibition of leukocyte trafficking in inflammatory bowel disease","volume":"369","author":"Cominelli","year":"2013","journal-title":"N Engl J Med"},{"key":"2025082623441022000_61.6.92.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"2025082623441022000_61.6.92.3","first-page":"839","article-title":"The safety of Vedolizumab for ulcerative colitis and Crohn\u2019s disease","volume":"66","author":"Colombel","year":"2017","journal-title":"BMJ"},{"key":"2025082623441022000_61.6.92.4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2017.08.008","article-title":"Interstitial nephritis secondary to Vedolizumab treatment in Crohn disease and safe rechallenge using steroids: a case report","volume":"71","author":"Bailly","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2025082623441022000_61.6.92.5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"2025082623441022000_61.6.92.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2505"},{"key":"2025082623441022000_61.6.92.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316023"},{"key":"2025082623441022000_61.6.92.8","unstructured":"WHO . VigiBase\u00ae, the World Health Organization\u2019s global database for ADRs, maintained by the Uppsala Monitoring Centre, 2021. VigiAccess Uppsala Monitoring Centre. Available: http:\/\/www.vigiaccess.org\/ [Accessed February 2021]."},{"key":"2025082623441022000_61.6.92.9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/01913123.2020.1839152","article-title":"Electron microscopic findings can support multiple etiologies of nephrotoxicity in renal tubules","volume":"44","author":"Zhang","year":"2020","journal-title":"Ultrastruct Pathol"},{"key":"2025082623441022000_61.6.92.10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04660513"},{"key":"2025082623441022000_61.6.92.11","first-page":"3","article-title":"Drug-Induced acute interstitial nephritis: pathology, pathogenesis, and treatment","volume":"9","author":"Krishnan","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"2025082623441022000_61.6.92.12","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07630717"},{"key":"2025082623441022000_61.6.92.13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.71"},{"key":"2025082623441022000_61.6.92.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002776"},{"key":"2025082623441022000_61.6.92.15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.89"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2022.243568.rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:44:17Z","timestamp":1756277057000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2022.243568.rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,31]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/dtb.2022.243568.rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2022.243568.rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}